ANIK Earnings

Quarterly EPS
$-2.03
Q3 2024
$-1.50
Q4 2024
$-0.34
Q1 2025
$-0.28
Q2 2025
$-0.16
Q3 2025
$0.02
Q4 2025
$-0.37
Q1 2026
$0.25
Q2 2026
Latest Revenue32.6M
Latest Net Income3.3M
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026$0.2532.6M3.3M+15.6%+189.3%
Q1 2026-$0.3729.6M-5056000+13.2%-8.8%
Q4 2025$0.0230.6M292.0K+0.0%+101.3%
Q3 2025-$0.1627.8M-2329000-5.9%+92.1%
Q2 2025-$0.2828.2M-3970000-8.2%-2,700.0%
Q1 2025-$0.3426.2M-4873000-9.8%-9.7%
Q4 2024-$1.5030.6M-21865000-28.8%+65.1%
Q3 2024-$2.0329.6M-29918000-28.7%-351.1%
Q2 2024-$0.0130.7M-88000
Q1 2024-$0.3129.0M-4514000
Q4 2023-$4.3043.0M-63000000
Q3 2023-$0.4541.5M-6576000
Anika Therapeutics (ANIK) — Earnings